What is LOPJLB’s current signal on ANRO?

LOPJLB’s latest quantitative signal on Alto Neuroscience, Inc. (ANRO) is BUY in a BULL regime. Signals are updated daily.

What market regime is ANRO in?

Alto Neuroscience, Inc. (ANRO) is currently classified in the BULL HMM market regime on LOPJLB.

What does Alto Neuroscience, Inc. (ANRO) do?

Alto Neuroscience, Inc. operates as a biopharmaceutical entity in the clinical stage, specializing in the creation of novel psychiatric medications. Its development pipeline includes ALTO-100, an investigational therapy targeting individuals affected by major depressive disorder (MDD) and post-traumatic stress disorder. Also in its portfolio is ALTO-300, a small molecule designed to function as…

Where is Alto Neuroscience, Inc. based / listed?

Alto Neuroscience, Inc. is based in US, listed on NYSE.

Alto Neuroscience, Inc. (ANRO) Stock · BUY · BULL

Key stats

Short interest · FINRA settlement 2026-07-31

Market cap: $1.3B
Avg volume: 459.2K
Beta: 1.09
P/E (TTM): -14.62

Short % float: 9.21%
Days to cover: 7.5
SI change: +4.5%

1W: +7.89%
1M: +35.36%
3M: +70.83%
YTD: +118.51%

vs SPY 1W: +9.08%
vs SPY 1M: +32.04%
vs SPY 3M: +68.44%
vs SPY YTD: +106.75%

Sector peers

Same-sector names ranked by LOPJLB quality proximity · Healthcare

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Alto Neuroscience, Inc. (ANRO)

Key stats

Sector peers

Industry peers

Prediction markets

ANALYST & RATINGS

Company news